Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian F Thomas

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Neuropharmacology|July 25, 2016
Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in miceJenny L Wiley, Timothy W Lefever, Julie A Marusich, et al.
Bioorganic & Medicinal Chemistry|March 12, 2003
Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinolsJohn W Huffman, John R A Miller, John Liddle, et al.
Journal of Neurodevelopmental Disorders|January 9, 2023
Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatmentJoseph M Palumbo, Brian F Thomas, Dejan Budimirovic, et al.
Frontiers in Physiology|July 5, 2016
Medullary Endocannabinoids Contribute to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System ExpressionChris L Schaich, Megan Grabenauer, Brian F Thomas, et al.
Water Resources Research|February 23, 2016
Quantifying renewable groundwater stress with GRACEAlexandra S Richey, Brian F Thomas, Min-Hui Lo, et al.
Journal of Medicinal Chemistry|October 10, 2019
Synthesis and Pharmacological Evaluation of 1-Phenyl-3-Thiophenylurea Derivatives as Cannabinoid Type-1 Receptor Allosteric ModulatorsThuy Nguyen, Thomas F Gamage, Ann M Decker, et al.
Bioorganic & Medicinal Chemistry|March 24, 2015
Structure-activity relationships of substituted 1H-indole-2-carboxamides as CB1 receptor allosteric modulatorsThuy Nguyen, Nadezhda German, Ann M Decker, et al.
Forensic Toxicology|February 2, 2019
Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperaturesRichard C Kevin, Alexander L Kovach, Timothy W Lefever, et al.
Drug and Alcohol Dependence|November 5, 2018
Sex, THC, and hormones: Effects on density and sensitivity of CB<sub>1</sub> cannabinoid receptors in ratsCharlotte E Farquhar, Christopher S Breivogel, Thomas F Gamage, et al.
Substance Abuse : Research and Treatment|May 5, 2017
Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in MiceTimothy W Lefever, Julie A Marusich, Brian F Thomas, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Neuropharmacology|July 25, 2016
Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in miceJenny L Wiley, Timothy W Lefever, Julie A Marusich, et al.
Bioorganic & Medicinal Chemistry|March 12, 2003
Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinolsJohn W Huffman, John R A Miller, John Liddle, et al.
Journal of Neurodevelopmental Disorders|January 9, 2023
Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatmentJoseph M Palumbo, Brian F Thomas, Dejan Budimirovic, et al.
Frontiers in Physiology|July 5, 2016
Medullary Endocannabinoids Contribute to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System ExpressionChris L Schaich, Megan Grabenauer, Brian F Thomas, et al.
Water Resources Research|February 23, 2016
Quantifying renewable groundwater stress with GRACEAlexandra S Richey, Brian F Thomas, Min-Hui Lo, et al.
Journal of Medicinal Chemistry|October 10, 2019
Synthesis and Pharmacological Evaluation of 1-Phenyl-3-Thiophenylurea Derivatives as Cannabinoid Type-1 Receptor Allosteric ModulatorsThuy Nguyen, Thomas F Gamage, Ann M Decker, et al.
Bioorganic & Medicinal Chemistry|March 24, 2015
Structure-activity relationships of substituted 1H-indole-2-carboxamides as CB1 receptor allosteric modulatorsThuy Nguyen, Nadezhda German, Ann M Decker, et al.
Forensic Toxicology|February 2, 2019
Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperaturesRichard C Kevin, Alexander L Kovach, Timothy W Lefever, et al.
Drug and Alcohol Dependence|November 5, 2018
Sex, THC, and hormones: Effects on density and sensitivity of CB<sub>1</sub> cannabinoid receptors in ratsCharlotte E Farquhar, Christopher S Breivogel, Thomas F Gamage, et al.
Substance Abuse : Research and Treatment|May 5, 2017
Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in MiceTimothy W Lefever, Julie A Marusich, Brian F Thomas, et al.
Pageof 9